Ethics and IVF add-ons: We need to talk about it

Area of Science:

• Reproductive Medicine
• Medical Ethics

Background:

• In vitro fertilization (IVF) add-ons are supplementary treatments intended to increase success rates.
• Many IVF add-ons lack robust scientific evidence supporting their efficacy.
• Infertile patients often pursue these adjunct therapies due to a strong desire for conception.

Discussion:

• The widespread use of IVF add-ons raises ethical questions regarding patient safety and informed consent.
• Clinics frequently offer these treatments, sometimes with inaccurate or incomplete information about their benefits and risks.
• Vulnerable IVF patients may be unduly influenced by marketing, leading to the use of unproven interventions.

Key Insights:

• There is a significant gap between the marketing of IVF add-ons and the available clinical evidence.
• Patients are often unaware of the uncertainties and potential harms associated with these adjunct therapies.
• Ethical practice demands transparency regarding the efficacy and safety of all interventions in assisted reproduction.

Outlook:

• There is a critical need for clear guidelines and effective regulation governing the use and advertising of IVF add-ons.
• Enhanced transparency is essential to empower patients in making informed decisions about their fertility treatments.
• Future research should focus on rigorously evaluating the safety and effectiveness of commonly used IVF add-ons.